seed
Stage
2016
Founded
2
Investors
About
Cartilago is a clinical-stage regenerative medicine company developing disease-modifying technologies for osteoarthritis and related pathologies. They also create anti-aging solutions for skincare, utilizing proprietary peptidyl derivatives to stimulate tissue repair and regeneration.
Explore Cartilago's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.